Arbutus Biopharma Corp

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Tender offer statement by the issuer (amendment)

Tender offer statement by the issuer (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Tender offer statement by the issuer

Other Events

No description available

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Termination of a Material Definitive Agreement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Other Events

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Other Events

Other Events

Other Events

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Other Events

Other Events

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Other Events

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Prospectus Supplement for Primary Offering

06b

Notice of Effectiveness

Letter from the SEC

Correspondence with the SEC

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

No description available

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

No description available

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Definitive Proxy Statement

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Letter from the SEC

No description available

Correspondence with the SEC

Letter from the SEC

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

No description available

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Roivant Sciences Ltd.

Nguyen Tuan

Sawhney Roger

Beardsley Robert A

Androski Lindsay

Sawhney Roger

Beardsley Robert A

Androski Lindsay